Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer

被引：0
|
作者：
Kasabwala, Dimpal M.
Cristofanilli, Massimo
Alpaugh, R. Katherine
Chumsri, Saranya
Reduzzi, Carolina
Tang, Cha-Mei
Lapidus, Rena G.
Del Priore, Giuseppe
Williams, William V.
Adams, Daniel L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar V. S.
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    MODERN PATHOLOGY, 2016, 29 : 77A - 77A
  • [32] Investigation of PD-L1 expression in circulating tumor cells isolated using the Parsortix system in metastatic lung and breast cancer patients.
    Ciccioli, Mariacristina
    Davis, Amy
    Alenkhe, Ofure
    Pailhes-Jimenez, Anne-Sophie
    CANCER RESEARCH, 2021, 81 (13)
  • [33] PD-L1 on Circulating Tumor Cells Indicates Poor Prognosis in Breast Cancer
    Wang, Xue-fei
    Zhang, Guo-chao
    Wu, Sha-fei
    Li, Jia-xin
    Sun, Qiang
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (11):
  • [34] PD-L1 expressing circulating tumor cells (CTCs) in patients with breast cancer
    Zavridou, Martha
    Strati, Areti
    Malamos, Nikos
    Georgoulias, Vasilis
    Lianidou, Evi S.
    CANCER RESEARCH, 2016, 76
  • [35] PD-L1 protein expression in breast cancer
    Saastad, Sigurd A.
    Skjervold, Anette H.
    Ytterhus, Borgny
    Engstrom, Monica Jernberg
    Bofin, Anna M.
    JOURNAL OF CLINICAL PATHOLOGY, 2023,
  • [36] PD-L1 Expression on Circulating Epithelial tumour Cells (CETCS) Is Associated with Immune Evasion and Tumour Progression in Breast Cancer Patients and Differs from PD-L2 Expression
    Schott, Dorothea
    Pizon, Monika
    Pachmann, Ulrich
    Pachmann, Katharina
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 112 - 112
  • [37] PD-L1 expression on circulating epithelial tumor cells (CETCs) is associated with immune evasion and tumor progression in breast cancer patients and differs from PD-L2 expression
    Lux, D.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 198 - 198
  • [38] Increased PD-L1 expression in breast and colon cancer stem cells
    Wu, Yanheng
    Chen, Mingshui
    Wu, Peihong
    Chen, Chen
    Xu, Zhi Ping
    Gu, Wenyi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (05): : 602 - 604
  • [39] Analysis of PD-L1 Expression on Circulating Stromal and Tumor Cells in Lung Cancer Patients Treated with Chemoradiation Therapy and Atezolizumab
    Lin, S.
    Augustyn, A.
    He, J.
    Qiao, Y.
    Liao, Z.
    Raghavakaimal, A.
    Gardner, K.
    Heymach, J.
    Tsao, A.
    Adams, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S277 - S277
  • [40] Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression
    C. Van Berckelaer
    C. Rypens
    P. van Dam
    L. Pouillon
    M. Parizel
    K. A. Schats
    M. Kockx
    W. A. A. Tjalma
    P. Vermeulen
    S. van Laere
    F. Bertucci
    C. Colpaert
    L. Dirix
    Breast Cancer Research, 21
12345